Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten Drejer, CEO of Symphogen. Ph.D.

Re-painting the big pig-ture

Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Hormones make children fat

A new Danish million project will define the connection between hormons and obesity amongst children.

Medicult needs a word of advice

Medicult Board retains advisers, regarding the previous offer from Vitrolife.

Metabolic pro heads prefect post

The dean of the Department of Biomedicine at the Sahlgrenska Academy has appointed a new assistant prefect.

Top modern lab to Sahlgrenska

The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.

Apoteket gets new vice CEO

The Swedish government company Apoteket has recently appointed a vice CEO.

Swedish nanotech crosses the Atlantic

Genovis signs distribution agreement Finnzymes in US.

Think outside the... brain

Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.

Dupont gets new business manager

The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Schizophrenia and bipolar disorder are relatives

Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.

LEO Pharma - International Clinical Trial Manager

New map of eye proteins

A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.

Travelling scholarship to DTU professor

The Vera og Carl Johan Michaelsens Rejselegat has the founder of the Medicine and Technology program at DTU with a scholarship.

Laboratorieassistent till Olink

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.